PEPRA Intelligence · Public roadmapEvidence gates · Not target dates
Roadmap / Evidence-gated
Progress is earned. Not scheduled.
PEPRA advances only when the evidence for the next stage is real: source permission, user authorization, privacy, security, product validation, and a truthful operating boundary.
How to read this / 01
Each stage must prove its boundary.
Dates can create pressure to skip the difficult work. Evidence gates reverse that pressure: a stage stays closed until its permissions, controls, and product claims can be demonstrated.
Current stateLive synthetic preview
Current company statusPre-formation project
01
Stage 01
Live preview
Current
A public, synthetic demonstration of the intended product language and its educational boundaries.
Evidence required to hold this stage03 gates
Synthetic data is visibly labeled
No live integrations or genomic uploads
Science, privacy, genetic-data, and clinical boundaries are public
Public proof note
The preview is available now. It is not a live health service and does not analyze a real person.
02
Stage 02
Design partners
Not entered
Structured product feedback from explicitly identified participants before sensitive data enters the system.
Evidence required to hold this stage04 gates
Participant role and feedback scope documented
No implication of a commercial, clinical, or laboratory partnership
Research and feedback permissions separated from product consent
Feedback process avoids collection of unnecessary health or genetic data
Public proof note
PEPRA has no signed design partners. This gate remains closed until participation and boundaries are documented.
03
Stage 03
Controlled single-source beta
Gate closed
A narrow beta using one permitted data source, explicit authorization, and a deliberately limited educational purpose.
Evidence required to hold this stage05 gates
Written source permission or an approved official access path
Explicit user authorization and a working disconnect path
Data minimization, retention, deletion, and incident procedures tested
Provenance, missingness, and device-estimate labels preserved
No diagnosis, treatment selection, or prescription recommendation
Public proof note
No live data source is currently connected. A provider logo, API key, or technical prototype alone would not pass this gate.
04
Stage 04
Multi-source educational intelligence
Gate closed
Cross-source educational views only where each source permits the use and each signal retains its proper evidentiary weight.
Evidence required to hold this stage05 gates
Every source independently passes permission and security review
User authorization is granular, revocable, and source-specific
Cross-signal outputs expose provenance, uncertainty, and alternatives
Model evaluation covers unsupported inference and false-certainty risk
Only permitted data is processed for the disclosed educational purpose
Public proof note
No multi-source integration is live. This stage cannot inherit permission from an earlier source or from a user's access alone.
05
Stage 05
Independent clinical handoff
Gate closed
A clearly separated route to an independently operated clinical service, if one is lawfully established and available.
Evidence required to hold this stage05 gates
An identified licensed professional entity contracts under separate terms
Availability and licensure are verified for each applicable state
The clinician independently evaluates and decides whether care is appropriate
Educational output is not represented as a diagnosis or prescription
Clinical records, consent, support, and liability remain in the proper system
Public proof note
PEPRA has no signed clinician network or live clinical service. No clinical relationship exists through the current preview.
Cross-stage rules / 02
No gate can waive these.
01
No implied permission
User access does not automatically permit PEPRA access or use.
02
No certainty inflation
Multiple weak signals do not automatically become strong evidence.
03
No hidden clinical leap
Educational analysis does not select a diagnosis, drug, or peptide.
04
No fictional operating state
Planned partners, integrations, and services remain labeled as planned.
Public accountability / 03
The roadmap changes when the evidence does.
PEPRA is operated by Toliman AI LLC. The company has no signed clinical partners or operating clinical service. Any future status change should be reflected here only after it is verifiable.